Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4374-4380

  Lehane, Adele M ^a   Kirk, Kiaran ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HYDROGEN;

ALLELE; ARTICLE; CELL VACUOLE; DIGESTIVE SYSTEM; DRUG RESISTANCE; GENE; GENE MUTATION; GENETICS; HYPOTHESIS; NONHUMAN; PFCRT GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; HYDROGEN; MEMBRANE TRANSPORT PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; VACUOLES;

EID: 57049091831     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00666-08     Document Type: Article

References (47)

1. Bennett, T. N., A. D. Kosar, and P. D. Roepe. 2005. Plasmodium falciparum strain GC-03 exhibits hyper-gametocytogenesis in partially hemoglobin depleted red blood cells. Mol. Biochem. Parasitol. 139:261-265.
2. Bray, P. G., R. E. Martin, L. Tilley, S. A. Ward, K. Kirk, and D. A. Fidock. 2005. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol. Microbiol. 56:323-333.
3. Bray, P. G., M. Mungthin, I. M. Hastings, G. A. Biagini, D. K. Saidu, V. Lakshmanan, D. J. Johnson, R. H. Hughes, P. A. Stocks, P. M. O'Neill, D. A. Fidock, D. C. Warhurst, and S. A. Ward. 2006. PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol. Microbiol. 62:238-251.
4. Bray, P. G., K. J. Saliba, J. D. Davies, D. G. Spiller, M. R. White, K. Kirk, and S. A. Ward. 2002. Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH. Mol. Biochem. Parasitol. 119:301-304.
5. Chen, N., D. E. Kyle, C. Pasay, E. V. Fowler, J. Baker, J. M. Peters, and Q. Cheng. 2003. pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob. Agents Chemother. 47:3500-3505.
6. Cooper, R. A., M. T. Ferdig, X. Z. Su, L. M. B. Ursos, J. Mu, T. Nomura, H. Fujioka, D. A. Fidock, P. D. Roepe, and T. E. Wellems. 2002. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 61:35-42.
7. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. B. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
8. Fitch, C. D. 2004. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci. 74:1957-1972.
9. Fitch, C. D. 1970. Plasmodium falciparum in owl monkeys: drug resistance and chloroquine binding capacity. Science 169:289-290.
10. Francis, S. E., D. J. Sullivan, Jr., and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
11. Gligorijevic, B., T. Bennett, R. McAllister, J. S. Urbach, and P. D. Roepe. 2006. Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites. 2. Altered vacuolar volume regulation in drug resistant malaria. Biochemistry 45:12411-12423.
12. Hayward, R., K. J. Saliba, and K. Kirk. 2005. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol. Microbiol. 55:1285-1295.
13. Hayward, R., K. J. Saliba, and K. Kirk. 2006. The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance. J. Cell Sci. 119:1016-1025.
14. Jiang, H., J. J. Patel, M. Yi, J. Mu, J. Ding, R. Stephens, R. A. Cooper, M. T. Ferdig, and X. Z. Su. 2008. Genome-wide compensatory changes accompany drug-selected mutations in the Plasmodium falciparum crt gene. PLoS ONE 3:e2484.
15. Klonis, N., O. Tan, K. Jackson, D. Goldberg, M. Klemba, and L. Tilley. 2007. Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of haemoglobin in Plasmodium falciparum. Biochem. J. 407:343-354.
16. Krogstad, D. J., I. Y. Gluzman, D. E. Kyle, A. M. Oduola, S. K. Martin, W. K. Milhous, and P. H. Schlesinger. 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238:1283-1285.
17. Krogstad, D. J., P. H. Schlesinger, and I. Y. Gluzman. 1985. Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol. 101:2302-2309.
18. Kublin, J. G., J. F. Cortese, E. M. Njunju, R. A. Mukadam, J. J. Wirima, P. N. Kazembe, A. A. Djimde, B. Kouriba, T. E. Taylor, and C. V. Plowe. 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187:1870-1875.
19. Kuhn, Y., P. Rohrbach, and M. Lanzer. 2007. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin. Cell. Microbiol. 9:1004-1013.
20. Lakshmanan, V., P. G. Bray, D. Verdier-Pinard, D. J. Johnson, P. Horrocks, R. A. Muhle, G. E. Alakpa, R. H. Hughes, S. A. Ward, D. J. Krogstad, A. B. Sidhu, and D. A. Fidock. 2005. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO J. 24:2294-2305.
21. + leak from the digestive vacuole in chloroquine-resistant malaria parasites. J. Cell Sci. 121:1624-1632.
22. Martin, R. E., and K. Kirk. 2004. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol. Biol. Evol. 21:1938-1949.
23. Martin, S. K., A. M. Oduola, and W. K. Milhous. 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235:899-901.
24. Meredith, D. 2004. Site-directed mutation of arginine 282 to glutamate uncouples the movement of peptides and protons by the rabbit proton-peptide cotransporter PepT1. J. Biol. Chem. 279:15795-15798.
25. Mita, T., A. Kaneko, J. K. Lum, B. Bwijo, M. Takechi, I. L. Zungu, T. Tsukahara, K. Tanabe, T. Kobayakawa, and A. Bjorkman. 2003. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am. J. Trop. Med. Hyg. 68:413-415.
26. Orjih, A. U., J. S. Ryerse, and C. D. Fitch. 1994. Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine. Experientia 50:34-39.
27. Pagola, S., P. W. Stephens, D. S. Bohle, A. D. Kosar, and S. K. Madsen. 2000. The structure of malaria pigment beta-haematin. Nature 404:307-310.
28. +-pyrophosphatase. J. Biol. Chem. 278:5605-5612.
29. Saliba, K. J., P. I. Folb, and P. J. Smith. 1998. Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem. Pharmacol. 56:313-320.
30. Sanchez, C. P., J. E. McLean, P. Rohrbach, D. A. Fidock, W. D. Stein, and M. Lanzer. 2005. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44:9862-9870.
31. Sanchez, C. P., J. E. McLean, W. Stein, and M. Lanzer. 2004. Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 43:16365-16373.
32. Sanchez, C. P., P. Rohrbach, J. E. McLean, D. A. Fidock, W. D. Stein, and M. Lanzer. 2007. Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum. Mol. Microbiol. 64:407-420.
33. Sanchez, C. P., W. Stein, and M. Lanzer. 2003. Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry 42:9383-9394.
34. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
35. + exchanger. Mol. Biochem. Parasitol. 162:96-99.
36. Su, X., L. A. Kirkman, H. Fujioka, and T. E. Wellems. 1997. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91:593-603.
37. Tran, C. V., and M. H. Saier, Jr. 2004. The principal chloroquine resistance protein of Plasmodium falciparum is a member of the drug/metabolite transporter superfamily. Microbiology 150:1-3.
38. Trape, J. F. 2001. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64:12-17.
39. van Schalkwyk, D. A., and T. J. Egan. 2006. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. Drug Resist. Updates 9:211-226.
40. Wang, X., J. Mu, G. Li, P. Chen, X. Guo, L. Fu, L. Chen, X. Su, and T. E. Wellems. 2005. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am. J. Trop. Med. Hyg. 72:410-414.
41. Warhurst, D. C., J. C. Craig, and I. S. Adagu. 2002. Lysosomes and drug resistance in malaria. Lancet 360:1527-1529.
42. Wellems, T. E., L. J. Panton, I. Y. Gluzman, V. E. do Rosario, R. W. Gwadz, A. Walker-Jonah, and D. J. Krogstad. 1990. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345:253-255.
43. Wellems, T. E., A. Walker-Jonah, and L. J. Panton. 1991. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc. Natl. Acad. Sci. USA 88:3382-3386.
44. Wissing, F., C. P. Sanchez, P. Rohrbach, S. Ricken, and M. Lanzer. 2002. Illumination of the malaria parasite Plasmodium falciparum alters intracellular pH. Implications for live cell imaging. J. Biol. Chem. 277:37747-37755.
45. Yayon, A. 1985. The antimalarial mode of action of chloroquine. Rev. Clin. Basic Pharm. 5:99-139.
46. Yayon, A., Z. I. Cabantchik, and H. Ginsburg. 1984. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3:2695-2700.
47. Yayon, A., Z. I. Cabantchik, and H. Ginsburg. 1985. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. USA 82:2784-2788.